Jan. 12, 2024
by Basem Goueli, M.D., Ph.D., MBA
Biopharma insight
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
Jan. 12, 2024
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
Jan. 12, 2024
by Basem Goueli MD/PhD/MBA
Biopharma insight
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
Jan. 12, 2024
by Basem Goueli MD/PhD/MBA
Biopharma insight
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Jan. 11, 2024
by Michael Whitworth, Trevor Hutchings, Alex Jones
Biopharma insight
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
Jan. 10, 2024
by Emma Banks
Biopharma insight
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside …
Jan. 10, 2024
by Andrii Buvailo
Biopharma insight
Researchers at the Massachusetts Institute of Technology (MIT) have made significant advancement in the study of cellular processes such as cancer …
Jan. 9, 2024
by Andrii Buvailo
Biopharma insight
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Jan. 7, 2024
by Dana Sokolova
Biopharma insight
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Jan. 5, 2024
by Irina Bilous, Andrii Buvailo
Biopharma insight
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Dec. 28, 2023
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
The sphere of oncology continues to grapple with the complex nature of brain and central nervous system (CNS) tumors. Data …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …